Lisa McCann - Alpha Teknova Chief Officer

TKNO Stock  USD 8.84  0.66  6.95%   

Insider

Lisa McCann is Chief Officer of Alpha Teknova
Age 42
Phone831 637 1100
Webhttps://www.teknova.com

Alpha Teknova Management Efficiency

The company has return on total asset (ROA) of (0.151) % which means that it has lost $0.151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4151) %, meaning that it created substantial loss on money invested by shareholders. Alpha Teknova's management efficiency ratios could be used to measure how well Alpha Teknova manages its routine affairs as well as how well it operates its assets and liabilities.
Alpha Teknova currently holds 30.46 M in liabilities with Debt to Equity (D/E) ratio of 0.27, which may suggest the company is not taking enough advantage from borrowing. Alpha Teknova has a current ratio of 6.62, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Alpha Teknova's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Albert BollesLifecore Biomedical
67
Keith LavanPetros Pharmaceuticals
60
Elizabeth JDANI Pharmaceuticals
N/A
BA EsqOrganogenesis Holdings
55
Brian GrowOrganogenesis Holdings
49
YatGai AuRegencell Bioscience Holdings
52
Muthusamy RPhANI Pharmaceuticals
57
Wai ChungRegencell Bioscience Holdings
48
Richard MDCollegium Pharmaceutical
64
Patricio MunozProcaps Group SA
52
David FranciscoOrganogenesis Holdings
59
Patrick BilboOrganogenesis Holdings
63
Jean FilippiPhibro Animal Health
N/A
Kurt MathesonOrganogenesis Holdings
N/A
Zorina PitkinOrganogenesis Holdings
N/A
Alex DasallaCollegium Pharmaceutical
N/A
Marlo ManningCollegium Pharmaceutical
N/A
Scott SudduthCollegium Pharmaceutical
N/A
Robert WeinsteinPetros Pharmaceuticals
64
Damian FinioPhibro Animal Health
54
Melissa AngeliniProcaps Group SA
N/A
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. The company was founded in 1996 and is headquartered in Hollister, California. Alpha Teknova operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 237 people. Alpha Teknova (TKNO) is traded on NASDAQ Exchange in USA. It is located in 2451 Bert Dr., Hollister, CA, United States, 95023 and employs 210 people. Alpha Teknova is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Alpha Teknova Leadership Team

Elected by the shareholders, the Alpha Teknova's board of directors comprises two types of representatives: Alpha Teknova inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alpha. The board's role is to monitor Alpha Teknova's management team and ensure that shareholders' interests are well served. Alpha Teknova's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alpha Teknova's outside directors are responsible for providing unbiased perspectives on the board's policies.
Damon JD, Chief Counsel
Matthew Lowell, Chief Officer
Ken Gelhaus, Chief Officer
Damon Terrill, Chief Counsel
Jennifer Henry, Senior Marketing
Stephen Gunstream, CEO President
Lisa McCann, Chief Officer

Alpha Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alpha Teknova a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Alpha Teknova

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alpha Teknova position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpha Teknova will appreciate offsetting losses from the drop in the long position's value.

Moving against Alpha Stock

  0.59MD Mednax IncPairCorr
  0.59NHC National HealthCarePairCorr
  0.53PNTG Pennant GroupPairCorr
  0.5EHC Encompass Health Corp Earnings Call This WeekPairCorr
  0.49SEM Select Medical HoldingsPairCorr
The ability to find closely correlated positions to Alpha Teknova could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alpha Teknova when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alpha Teknova - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alpha Teknova to buy it.
The correlation of Alpha Teknova is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alpha Teknova moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alpha Teknova moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alpha Teknova can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Alpha Teknova offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alpha Teknova's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alpha Teknova Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alpha Teknova Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Alpha Teknova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Alpha Stock, please use our How to Invest in Alpha Teknova guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alpha Teknova. If investors know Alpha will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alpha Teknova listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alpha Teknova is measured differently than its book value, which is the value of Alpha that is recorded on the company's balance sheet. Investors also form their own opinion of Alpha Teknova's value that differs from its market value or its book value, called intrinsic value, which is Alpha Teknova's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alpha Teknova's market value can be influenced by many factors that don't directly affect Alpha Teknova's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alpha Teknova's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alpha Teknova is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alpha Teknova's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.